HOME › DRUGS › MOLNUPIRAVIR
ACTIVE SUBSTANCE / INN

MOLNUPIRAVIR

Brand name(s): Lagevrio
EMA LISTED
APPLICATION WITHDRAWN
COVID-19 virus infection
ACTIVE SUBSTANCE
Molnupiravir
REGULATORS
EMA
SPONSORS / MAH
Merck Sharp & Dohme B.V. 
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
LagevrioMerck Sharp & Dohme B.V. Application withdrawnCOVID-19 virus infection

FULL INTELLIGENCE ON MOLNUPIRAVIR

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →